Mid-trimester fetal-placental velocimetry response to nifedipine may predict early the onset of pre-eclampsia

In Vivo

Volumn 20, Issue 1, 2006, Pages 183-186

  Cobellis, Luigi ^a   De Luca, Antonio ^a   Pecori, Emilia ^a   Mastrogiacomo, Annunziata ^a   Di Pietto, Laura ^a   Iannella, Iolanda ^a   Fornaro, Felice ^a   Scaffa, Cono ^a   Cobellis, Giovanni ^a   Colacurci, Nicola ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Doppler; Fetal growth restriction; Fetal placental blood flow; Hypertesion; Placenta; Pre eclampsia; Pregnancy; Preterm

Indexed keywords

NIFEDIPINE;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOPPLER FLOWMETRY; DRUG RESPONSE; FEMALE; FETUS CIRCULATION; FISHER EXACT TEST; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; MIDDLE CEREBRAL ARTERY; PLACENTA PERFUSION; PREDICTION; PREECLAMPSIA; PULSATILE FLOW; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; STUDENT T TEST; SYSTOLIC BLOOD PRESSURE; UMBILICAL ARTERY; UTERINE ARTERY;

EID: 30844449426     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Redman CW and Sargent IL: Latest advances in understanding preeclampsia. Science 308: 1592-1594, 2005.
2. Reis FM, D'Antona D and Petraglia F: Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23: 230-257, 2002.
3. Roberts JM and Cooper DW: Pathogenesis and genetics of preeclampsia. Lancet 357: 53-56, 2001.
4. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR and van Asshe A: A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101: 669-674, 1994.
5. Roberts JM: Endothelial dysfunction in preclampsia. Semin Reprod Endocrinol 16: 5-15, 1998.
6. Page EW: The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 37: 291-293, 1939.
7. Neilson JP and Alfirevic Z: Doppler ultrasound in high risk pregnancies. In: Neilson JP, Crowther CA, Hodnett ED, Hofmeyr GJ (eds.). Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Cochrane Collaboration; issue 1. Oxford: Update Software, 1998.
8. Schneider EP and Schulman H: Doppler ultrasound in obstetrics and gynecology. In: Copel JA, Reed KL (eds.). Hypertension. New York: Raven Press, pp. 147-155, 1995.
9. Petraglia F, Florio P, Nappi C and Genazzani AR: Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev 17: 156-186, 1996.
10. Maigaard S: Contraction and relaxation of human uterine and placental smooth muscle. Endogenous control and calcium activation mechanisms. Acta Obstet Gynecol Scand 143: 1-39, 1987.
11. Guiet-Bara A, Ibrahim B, Leveteau J and Bara M: Calcium channels, potassium channels and membrane potential of smooth muscle cells of human allantochorial placental vessels. Bioelectrochem Bioenerg 48: 407-413, 1999.
12. 2+ agonist Bay K 8644 in human placental arteries. Gen Pharmacol 26: 989-996, 1995.
13. Richichi J and Vasilenko P: The effects of nifedipine on pregnancy outcome and morphology of the placenta, uterus, and cervix during late pregnancy in the rat. Am J Obstet Gynecol 167: 797-803, 1992.
14. 2+ antagonists nifedipine and diltiazem on isolated human chorionic arteries and veins. J Cardiovasc Pharmacol 16: 128-138, 1990.
15. Marin J, Revinego J, Fernandez-Alfonso MS and Guerra P: Effect of nifedipine in arterial vasculature of human placenta. Gen Pharmacol 21: 629-633, 1990.
16. Forman A, Andersson KE and Maigaard S: Effects of calcium channel blockers on the female genital tract. Acta Pharmacol Toxicol (Copenh) 58: 183-192, 1986.
17. Severi FM, Bocchi C, Visentin A, Falco P, Cobellis L, Florio P et al: Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler. Ultrasound Obstet Gynecol 19: 225-228, 2002.
18. National High Blood Pressure Education Program. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183: S1-S22, 2000.
19. Yudkin PL, Aboualfa M, Eyre J, Redman CW and Wilkinson AR: New birthweight and head circumference centiles for gestational ages 24 to 42 weeks. Early Hum Dev 15: 45-52, 1987.
20. Moretti MM, Fairlie FM, Akl S, Khoury AD and Sibai BM: The effect of nifedipine therapy on fetal and placental Doppler waveforms in preeclampsia remote from term. Am J Obstet Gynecol 163: 1844-1848, 1990.
21. Duggan PM, McCowan LM and Stewart AW: Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension. Aust NZ J Obstet Gynaecol 32: 335-338, 1992.
22. Granger JP, Alexander BT, Bennett WA and Khalil RA: Pathophysiology of pregnancy-induced hypertension. Am J Hypertens 14: 178S-185S, 2001.
23. Khedun SM, Moodley J, Naicker T and Maharaj B: Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 74: 221-258, 1997.
24. Papatsonis DN, Lok CA, Bos JM, Geijn HP and Dekker GA: Calcium channel blockers in the management of preterm labor and hypertension in pregnancy. Eur J Obstet Gynecol Reprod Biol 97: 122-140, 2001.
25. Taddei S, Virdis A, Ghiadoni L, Sudano I and Salvetti A: Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 62: 265-284, 2002.
26. Fried G and Liu YA: Effects of endothelin, calcium channel blockade and EDRF inhibition on the contractility of human uteroplacental arteries. Acta Physiol Scand 151: 477-484, 1994.
27. Liu YA, Ostlund E and Fried G: Endothelin-induced contractions in human placental blood vessels are enhanced in intrauterine growth retardation, and modulated by agents that regulate levels of intracellular calcium. Acta Physiol Scand 155: 405-414, 1995.
28. Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R et al: Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab 85: 2318-2323, 2000.
29. Schiff E, Ben-Baruch G, Peleg E, Rosenthal T, Alcalay M, Devir M et al: Immunoreactive circulating endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol 166: 624-628, 1992.
30. Papageorghiou AT, Yu CK and Nicolaides KH: The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 18: 383-396, 2004.
31. Marsal K: Rational use of Doppler ultrasound in perinatal medicine. J Perinat Med 22: 463-474, 1994.